Samante, Reniel Jay A.

HRN: 22-95-41  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/24/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/24/2023
05/01/2023
IV
1g
Q6
PCAP
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: